MHRA

Showing 15 posts of 96 posts found.

european_commission_web_5

MHRA to consult on potential for no-deal Brexit

October 5, 2018
Medical Communications EU, MHRA, brexit, uk politics

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …

drug_safety

Drug safety: UK and EU post-Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …

28246711066_52e38bc591_z

MHRA loses EMA contracts in wake of Brexit

September 3, 2018
Sales and Marketing EMA, MHRA, UK, brexit, contracts, politics, regulation

The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10

There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …

28246711066_52e38bc591_z

MHRA sets out Brexit implementation period plan

August 7, 2018
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, MHRA, UK, brexit, implentation period

The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …

MHRA bans sodium valproate in the UK following birth defect controversy

April 24, 2018
Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi, Sodium valproate, bipolar, epilepsy, pharma

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment …

top_ten

Top Ten most popular articles on Pharmafile.com this week

April 20, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, EMA, GW Pharma, J&J, JJ, MHRA, Mylan, Novartis, Sanofi, Shire, Takeda, biotech, drugs, epipen, keytruda, pharma, pharmaceutical

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …

Pfizer’s Viagra Connect becomes first erectile dysfunction drug available over-the-counter in UK

November 29, 2017
Research and Development, Sales and Marketing MHRA, Pfizer, Viagra Connect, erectile dysfunction, pharma, viagra

Pfizer has revealed that its erectile dysfunction treatment Viagra Connect (sildenafil) will now be available without a prescription through UK …

hiv_testing_kit

HIV home tests seized from market over potential risk

August 24, 2017
Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical

The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …

brexit_flag_0

Ministers move to clarify drug regulation Post-Brexit

July 4, 2017
Manufacturing and Production, Medical Communications EMA, Jeremy Hunt, MHRA, NHS, NICE

Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will …

sanofi_new_paris_hq

Patients in UK to be given early access to Sanofi’s eczema treatment

March 14, 2017
Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi

Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …

brexit

Brexit could delay key drugs to UK patients, ex-MHRA chairman claims

February 10, 2017
Medical Communications, Sales and Marketing Cancer, MHRA, brexit

Former UK regulator and ex-chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) Sir Alasdair Breckenridge has warned that …

social_media

Socially vigilant: Does pharmacovigilance need secondary data & social media?

February 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, pharmacovigilance

As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new …

MHRA accepts Roche’s Tecentriq into Early Access to Medicines scheme

January 25, 2017
Research and Development, Sales and Marketing MHRA, Roche, eams, tecentriq

Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …

Latest content